Targeting cathepsin B by cycloastragenol enhances anti-tumor immunity via inhibiting MHC-1 degradation and promoting the presentation of tumor antigen. Targeting cathepsin B by cycloastragenol enhances anti-tumor immunity via inhibiting MHC-1 degradation and promoting the presentation of tumor antigen
收藏NIAID Data Ecosystem2026-03-13 收录
官方服务:
资源简介:
This SuperSeries is composed of the SubSeries listed below. Overall design: Refer to individual Series
创建时间:
2022-02-22



